For research use only. Not for therapeutic Use.
Ftaxilide(Cat No.:I002477)is a novel antituberculosis agent that shows promising activity against Mycobacterium tuberculosis, the causative agent of tuberculosis. It exhibits potent antimycobacterial properties and is being investigated as a potential therapeutic option for the treatment of tuberculosis. Ftaxilide works by targeting specific pathways or mechanisms essential for the survival and replication of the bacteria. Its unique mode of action sets it apart from existing anti-TB drugs, making it a valuable addition to the armamentarium against tuberculosis.
Catalog Number | I002477 |
CAS Number | 19368-18-4 |
Molecular Formula | C16H15NO3 |
Purity | ≥95% |
Target | Bacterial |
Solubility | DMSO:40mg/mL |
Storage | Room Temperature |
IUPAC Name | 2-[(2,6-dimethylphenyl)carbamoyl]benzoic acid |
InChI | InChI=1S/C16H15NO3/c1-10-6-5-7-11(2)14(10)17-15(18)12-8-3-4-9-13(12)16(19)20/h3-9H,1-2H3,(H,17,18)(H,19,20) |
InChIKey | LLECMGGNFBKPRH-UHFFFAOYSA-N |
SMILES | CC1=C(C(=CC=C1)C)NC(=O)C2=CC=CC=C2C(=O)O |
Reference | <p style=/line-height:25px/> |